Skip to main content

Advertisement

SpringerLink
Log in

A quantitative assay for measuring of bovine immunodeficiency virus using a luciferase-based indicator cell line

  • Published:
Virologica Sinica

Abstract

In order to quantitate the bovine immunodeficiency virus (BIV) infection in vitro, a BIV indicator cell line (BIVL) was established by transfecting baby hamster kidney cells with reporter plasmids containing the firefly luciferase gene driven by a BIV long terminal repeat promoter. The BIV activates promoter activity of the LTR to express luciferase upon infection. BIV infection could therefore by quantified by detection of luciferase activity. Compared to standard assays used to detect BIV infection, the BIVL-based assay is 10 times more sensitive than the the CPE-based assay, and has similar sensitivity with the viral capsid protein Western blot assay. BIV indicator cell line could detect BIV infection specifically. Luciferase activity of BIV infected BIVL cells showed a time dependent manner, and 60 h post infection is the optimal time to detect BIV infection. Luciferase activity of BIVL cells correlates with the BIV capsid protein expression. Moreover, a linear relationship was found between MOI and the activated intensity of luciferase expression. In brief, the BIV indicator cell line is an easy, robust and quantitive method for monitoring BIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Avidan O, Bochner R Hizi A. 2006. The catalytic properties of the recombinant reverse transcriptase of bovine immunodeficiency virus. Virology, 351(1):42–57.

    Article  CAS  PubMed  Google Scholar 

  2. Barboric M, Taube R, Nekrep N, et al. 2000. Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus. J Virol, 74(13):6039–6044.

    Article  CAS  PubMed  Google Scholar 

  3. Blair W S, Isaacson J, Li X, et al. 2005. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. Antivir Res, 65(2):107–116.

    Article  CAS  PubMed  Google Scholar 

  4. Braun M J, Lahn S, Boyd A L, et al. 1988. Molecular cloning of biologically active proviruses of bovine immunodeficiency-like virus. Virology, 167(2):515–523.

    CAS  PubMed  Google Scholar 

  5. Carpenter S, Miller L D, Alexandersen S, et al. 1992. Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus. J Virol, 66(2):1074–1083.

    CAS  PubMed  Google Scholar 

  6. Garcia J M, Gao A, He P L, et al. 2009. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay. Antivir Res, 81(3):239–247.

    Article  CAS  PubMed  Google Scholar 

  7. Geng Y, Kashanchi F, Wood C. 1992. Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1. Virology, 187(2):832–836.

    Article  CAS  PubMed  Google Scholar 

  8. Gonda M A, Oberste M S, Garvey K J, et al. 1990. Development of the bovine immunodeficiency-like virus as a model of lentivirus disease. Developments in biological standardization, 72:97–110.

    CAS  PubMed  Google Scholar 

  9. Jones J, Rodgers J, Heil M, et al. 2007. High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds. Assay Drug Dev Technol, 5(2):181–189.

    Article  CAS  PubMed  Google Scholar 

  10. Kalvatchev Z, Walder R, Barrios M, et al. 1995. Acquired immune dysfunction in rabbits experimentally infected with an infectious molecular clone of the bovine immunodeficiency virus (BIV127). Viral Immunol, 8(3):159–164.

    Article  CAS  PubMed  Google Scholar 

  11. Krah D L. 1991. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity. Biologicals, 19(3):223–227.

    Article  CAS  PubMed  Google Scholar 

  12. Li S, Zhu J, Peng Y, et al. 2005. Characterization of BIV Env core: implication for mechanism of BIV-mediated cell fusion. Biochem Biophys Res Commun, 329(2):603–609.

    Article  CAS  PubMed  Google Scholar 

  13. Liu S H, Chen H X, Chen J T, et al. 1997. Isolation and identification of a bovine spuma virus isolate 3026. Virol Sin, 13(2):140–145. (in Chinese)

    CAS  Google Scholar 

  14. Liu Z Q, Sheridan D, Wood C. 1992. Identification and characterization of the bovine immunodeficiency-like virus tat gene. J Virol, 66(8):5137–5140.

    CAS  PubMed  Google Scholar 

  15. Mak C C, Brik A, Lerner D L, et al. 2003. Design and synthesis of broad-based mono-and bi-cyclic inhibitors of FIV and HIV proteases. Bioorg Med Chem, 11(9):2025–2040.

    Article  CAS  PubMed  Google Scholar 

  16. Norelli S, El D S, D’Ostilio D, et al. 2008. Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1. Curr HIV Res, 6(4):306–317.

    Article  CAS  PubMed  Google Scholar 

  17. Ochsenbauer-Jambor C, Jones J, Heil M, et al. 2006. T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication. Biotechniques, 40(1):91–100.

    Article  CAS  PubMed  Google Scholar 

  18. Pifat D Y, Ennis W H, Ward J M, et al. 1992. Persistent infection of rabbits with bovine immunodeficiency-like virus. J Virol, 66(7):4518–4524.

    CAS  PubMed  Google Scholar 

  19. St-Louis M C, Cojocariu M, Archambault D. 2004. The molecular biology of bovine immunodeficiency virus: a comparison with other lentiviruses. Animal health research reviews / Conference of Research Workers in Animal Diseases, 5(2):125–143.

    CAS  PubMed  Google Scholar 

  20. Tobin G J, Ennis W H, Clanton D J, et al. 1996. Inhibition of bovine immunodeficiency virus by anti-HIV-1 compounds in a cell culture-based assay. Antivir Res, 33(1):21–31.

    Article  CAS  PubMed  Google Scholar 

  21. Wang D, Geng Y Q, Xu W R, et al. 1996. An experimental model for screening anti — AIDS drugs with bovine immunodeficiency virus. Chin J Pharmacol Toxicol, 10(1):49–52.

    Article  CAS  Google Scholar 

  22. Xuan C, Qiao W, Li J, et al. 2008. BTat, a trans-acting regulatory protein, contributes to bovine immunodeficiency virus-induced apoptosis. Cell Microbiol, 10(1):31–40.

    CAS  PubMed  Google Scholar 

  23. Xuan C H, Qiao W T, Li J, et al. 2008. BTat, a trans-acting regulatory protein, contributes to bovine immunodeficiency virus-induced apoptosis. Cell Microbiol, 10(1):31–40.

    CAS  PubMed  Google Scholar 

  24. Yang G, Paintsil E, Dutschman G E, et al. 2009. Impact of Novel HIV-1 Reverse Transcriptase Mutations, P119S and T165A on 4′-ethynylthymidine Analog Resistance Profile. Antimicrob Agents Chemother.

  25. Yang Y S, Chen G M, Dong W P, et al. 2003. Construction and analysis of activity of an HIV-1/bovine immunodeficiency virus chimeric clone cDNA. Chin J Exp clin virol, 17(2):143–145.(in Chinese)

    CAS  Google Scholar 

  26. Zheng L, Swanson M, Liao J, et al. 2000. Cloning of the bovine immunodeficiency virus gag gene and development of a recombinant-protein-based enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol, 7(4):557–562.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Nankai University, Tianjin, 300071, China

    Xue Yao, Hong-yan Guo, Xuan Xu, Jian-sen Du, Hao-yue Liang, Yun-qi Geng & Wen-tao Qiao

  2. Key Laboratory of Microbial Functional Genomics (Tianjin), Nankai University, Tianjin, 300071, China

    Xue Yao, Hong-yan Guo, Xuan Xu, Jian-sen Du, Hao-yue Liang, Yun-qi Geng & Wen-tao Qiao

  3. School of Medicine, Nankai University, Tianjin, 300071, China

    Chang Liu

Authors
  1. Xue Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong-yan Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xuan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian-sen Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hao-yue Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yun-qi Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wen-tao Qiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-tao Qiao.

Additional information

Foundation items: The General Foundation of Tianjin Science Committee for Applied Basic Research (08JCZDJC21000) and Chinese Ministry of Education (30770081)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, X., Guo, Hy., Liu, C. et al. A quantitative assay for measuring of bovine immunodeficiency virus using a luciferase-based indicator cell line. Virol. Sin. 25, 137–144 (2010). https://doi.org/10.1007/s12250-010-3109-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-010-3109-1

Key words

Search

Navigation